StoneRisk® Panel
Also known as: Stone Analysis, Kidney, Kidney Stone
Use
The StoneRisk® Panel (previously named StoneRisk® Diagnostic Profile) is intended to evaluate urinary excretion parameters associated with kidney stone risk by measuring multiple analytes, supersaturation indices, and urinary volume to aid clinicians in assessing and managing nephrolithiasis risk. The combined results inform metabolic evaluation and guide preventive strategies.
Special Instructions
This test is not available for New York patient testing, per the revision message effective July 29, 2024, updated July 31, 2024. The performing site transitioned from Quest Diagnostics Nichols Institute, Valencia to Quest Diagnostics Nichols Institute, San Juan Capistrano.
Limitations
Limitations include that this test requires accurate 24‑hour urine collection to ensure valid results; incomplete or improper collection may lead to inaccurate supersaturation calculations. Additionally, regional restrictions (e.g., New York) limit availability; differences in specimen handling or performing site transitions may affect interpretation timelines.
Methodology
Automated Analyzer (Clinical Chemistry)
Biomarkers
LOINC Codes
- 3167-4
- 27378-9
- 6874-2
- 2701-1
- 3087-4
- 6687-8
- 2956-1
- 26889-6
- 2779-7
- 24447-5
- 25308-8
- 2829-0
- 2162-6
- 34736-9
- 42673-4
- 43423-3
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
Not provided
Minimum Volume
Not provided